Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.
- DOI
- 10.1007/s13300-026-01875-3
- Published
- 2026 Jun
- Container
- Diabetes therapy : research, treatment and education of diabetes and related disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13300-026-01875-3,
title = {Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.},
author = {Navas A and Noone J and Laney N and Sheth S and Tan X and Liang Y and Munoz P and Swift C},
year = {2026},
journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
doi = {10.1007/s13300-026-01875-3},
url = {https://doi.org/10.1007/s13300-026-01875-3}
}RIS
TY - JOUR TI - Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category. AU - Navas A AU - Noone J AU - Laney N AU - Sheth S AU - Tan X AU - Liang Y AU - Munoz P AU - Swift C PY - 2026 JO - Diabetes therapy : research, treatment and education of diabetes and related disorders DO - 10.1007/s13300-026-01875-3 UR - https://doi.org/10.1007/s13300-026-01875-3 ER -
APA
A, N., J, N., N, L., S, S., X, T., Y, L., P, M., & C, S. (2026). Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category.. Diabetes therapy : research, treatment and education of diabetes and related disorders. https://doi.org/10.1007/s13300-026-01875-3
Source records
- pubmed · retrieved 2026-09-25T04:19:27.958Z